PE-VC Fund Investments
Think Investments, 360 ONE Funds invest Rs.140-Cr in Rubicon Research; GA exits
Think Investments (via its unit TIMF Holdings) and 360 ONE funds have invested INR 140 crore in Thane-based pharmaceutical company Rubicon Research in a pre-IPO funding round. As part of the transaction, existing PE investor General Atlantic (via General Atlantic Singapore RR Pte. Ltd) transferred 28.89 lakh equity shares to TIMF Holdings and 360 ONE funds at INR 484.47 per share.Founded in 1999, Rubicon Research is a pharmaceutical formulations company that currently operates two US R&D facilities (one in India and another in Canada), along with two manufacturing plants in India.
Between Aug 2007 and Aug 2025, Rubicon Research had attracted about USD 282 M from Kotak Alternate, Everstone, General Atlantic, Amansa Capital and others.For FY24, Rubicon Research had reported about INR 854 Cr in Operating Income and about INR 91 Cr in PAT.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
